Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vagal Stimulation in POTS - The Autonomic Inflammatory Reflex (Pilot 3)

Trial Profile

Vagal Stimulation in POTS - The Autonomic Inflammatory Reflex (Pilot 3)

Phase of Trial: Phase I

Latest Information Update: 06 Feb 2019

At a glance

  • Drugs Galantamine (Primary) ; Pyridostigmine (Primary)
  • Indications Postural orthostatic tachycardia syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Sep 2017 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
    • 14 Sep 2017 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2020.
    • 14 Sep 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top